University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...

West Virginia University (WVU), one of the top public research institutions in the nation, has formed a strategic partnership ...

Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 202 ...

The AlphaMeld platform empowers key functional stakeholders, including those involved in early drug discovery, target identification, competitive intelligence, and clinical trial optimization. By ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

BioAge has also entered a strategic collaboration with Lilly ExploR&D (part of Lilly Catalyze360) to discover two therapeutic antibodies that address novel metabolic aging targets identified by BioAge ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...